Dianthus Therapeutics Banner

Event Details

DIANTHUS THERAPEUTICS ANNOUNCES FDA CLEARANCE TO INITIATE PHASE 2 TRIAL OF DNTH103 IN MULTIFOCAL MOTOR NEUROPATHY (MMN)

Jefferies Global Healthcare Conference

Jun 6, 2024 1:30 PM EDT